nodes	percent_of_prediction	percent_of_DWPC	metapath
Betahistine—Cutaneous hypersensitivity—Gemcitabine—pancreatic cancer	0.029	0.0481	CcSEcCtD
Betahistine—Cutaneous hypersensitivity—Docetaxel—pancreatic cancer	0.0206	0.0341	CcSEcCtD
Betahistine—Dermatitis atopic—Gemcitabine—pancreatic cancer	0.00957	0.0159	CcSEcCtD
Betahistine—Vasodilation—Irinotecan—pancreatic cancer	0.00827	0.0137	CcSEcCtD
Betahistine—Vasodilation procedure—Irinotecan—pancreatic cancer	0.00827	0.0137	CcSEcCtD
Betahistine—Dermatitis atopic—Docetaxel—pancreatic cancer	0.00679	0.0113	CcSEcCtD
Betahistine—Abdominal pain upper—Sunitinib—pancreatic cancer	0.00585	0.0097	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Tamoxifen—pancreatic cancer	0.00571	0.00948	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Erlotinib—pancreatic cancer	0.00565	0.00938	CcSEcCtD
Betahistine—Abdominal distension—Sunitinib—pancreatic cancer	0.00557	0.00924	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Sunitinib—pancreatic cancer	0.00489	0.00812	CcSEcCtD
Betahistine—Erythema multiforme—Tamoxifen—pancreatic cancer	0.00489	0.00811	CcSEcCtD
Betahistine—Erythema multiforme—Erlotinib—pancreatic cancer	0.00484	0.00803	CcSEcCtD
Betahistine—Orthostatic hypotension—Irinotecan—pancreatic cancer	0.00482	0.00799	CcSEcCtD
Betahistine—Abdominal distension—Irinotecan—pancreatic cancer	0.00459	0.00762	CcSEcCtD
Betahistine—Dermatitis atopic—Epirubicin—pancreatic cancer	0.00458	0.0076	CcSEcCtD
Betahistine—Flatulence—Erlotinib—pancreatic cancer	0.00439	0.00728	CcSEcCtD
Betahistine—Bronchospasm—Gemcitabine—pancreatic cancer	0.00437	0.00725	CcSEcCtD
Betahistine—Dermatitis atopic—Doxorubicin—pancreatic cancer	0.00424	0.00703	CcSEcCtD
Betahistine—Erythema multiforme—Sunitinib—pancreatic cancer	0.00419	0.00695	CcSEcCtD
Betahistine—Angioedema—Tamoxifen—pancreatic cancer	0.00412	0.00683	CcSEcCtD
Betahistine—Immune system disorder—Sunitinib—pancreatic cancer	0.004	0.00664	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Gemcitabine—pancreatic cancer	0.00393	0.00651	CcSEcCtD
Betahistine—Vasodilation—Epirubicin—pancreatic cancer	0.00386	0.0064	CcSEcCtD
Betahistine—Vasodilation procedure—Epirubicin—pancreatic cancer	0.00386	0.0064	CcSEcCtD
Betahistine—Flatulence—Sunitinib—pancreatic cancer	0.0038	0.00631	CcSEcCtD
Betahistine—Discomfort—Tamoxifen—pancreatic cancer	0.00379	0.00628	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—pancreatic cancer	0.00377	0.00625	CcSEcCtD
Betahistine—Ventricular extrasystoles—Epirubicin—pancreatic cancer	0.00375	0.00622	CcSEcCtD
Betahistine—Vasodilation—Doxorubicin—pancreatic cancer	0.00357	0.00592	CcSEcCtD
Betahistine—Vasodilation procedure—Doxorubicin—pancreatic cancer	0.00357	0.00592	CcSEcCtD
Betahistine—Nervous system disorder—Erlotinib—pancreatic cancer	0.00357	0.00592	CcSEcCtD
Betahistine—Skin disorder—Erlotinib—pancreatic cancer	0.00353	0.00586	CcSEcCtD
Betahistine—Angioedema—Sunitinib—pancreatic cancer	0.00353	0.00585	CcSEcCtD
Betahistine—Ventricular extrasystoles—Doxorubicin—pancreatic cancer	0.00347	0.00576	CcSEcCtD
Betahistine—Erythema multiforme—Gemcitabine—pancreatic cancer	0.00336	0.00558	CcSEcCtD
Betahistine—Convulsion—Sunitinib—pancreatic cancer	0.00334	0.00554	CcSEcCtD
Betahistine—Orthostatic hypotension—Docetaxel—pancreatic cancer	0.00333	0.00553	CcSEcCtD
Betahistine—Abdominal pain upper—Docetaxel—pancreatic cancer	0.00333	0.00553	CcSEcCtD
Betahistine—Immune system disorder—Irinotecan—pancreatic cancer	0.0033	0.00547	CcSEcCtD
Betahistine—Dyspnoea—Tamoxifen—pancreatic cancer	0.00328	0.00544	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—pancreatic cancer	0.00326	0.00541	CcSEcCtD
Betahistine—Dyspnoea—Erlotinib—pancreatic cancer	0.00324	0.00538	CcSEcCtD
Betahistine—Dyspepsia—Tamoxifen—pancreatic cancer	0.00324	0.00537	CcSEcCtD
Betahistine—Immune system disorder—Gemcitabine—pancreatic cancer	0.00321	0.00533	CcSEcCtD
Betahistine—Dyspepsia—Erlotinib—pancreatic cancer	0.0032	0.00531	CcSEcCtD
Betahistine—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.00317	0.00526	CcSEcCtD
Betahistine—Fatigue—Tamoxifen—pancreatic cancer	0.00317	0.00526	CcSEcCtD
Betahistine—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.00314	0.00521	CcSEcCtD
Betahistine—Fatigue—Erlotinib—pancreatic cancer	0.00314	0.0052	CcSEcCtD
Betahistine—Flatulence—Irinotecan—pancreatic cancer	0.00313	0.00519	CcSEcCtD
Betahistine—Bronchospasm—Docetaxel—pancreatic cancer	0.0031	0.00514	CcSEcCtD
Betahistine—Nervous system disorder—Sunitinib—pancreatic cancer	0.00309	0.00512	CcSEcCtD
Betahistine—Skin disorder—Sunitinib—pancreatic cancer	0.00306	0.00507	CcSEcCtD
Betahistine—Ill-defined disorder—Irinotecan—pancreatic cancer	0.00295	0.00489	CcSEcCtD
Betahistine—Urticaria—Tamoxifen—pancreatic cancer	0.00292	0.00484	CcSEcCtD
Betahistine—Ill-defined disorder—Gemcitabine—pancreatic cancer	0.00287	0.00476	CcSEcCtD
Betahistine—Malaise—Irinotecan—pancreatic cancer	0.00287	0.00475	CcSEcCtD
Betahistine—Dyspnoea—Sunitinib—pancreatic cancer	0.00281	0.00466	CcSEcCtD
Betahistine—Malaise—Gemcitabine—pancreatic cancer	0.00279	0.00463	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Docetaxel—pancreatic cancer	0.00279	0.00462	CcSEcCtD
Betahistine—Dyspepsia—Sunitinib—pancreatic cancer	0.00277	0.0046	CcSEcCtD
Betahistine—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.00272	0.00451	CcSEcCtD
Betahistine—Fatigue—Sunitinib—pancreatic cancer	0.00271	0.0045	CcSEcCtD
Betahistine—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00271	0.00449	CcSEcCtD
Betahistine—Discomfort—Irinotecan—pancreatic cancer	0.00267	0.00443	CcSEcCtD
Betahistine—Asthenia—Tamoxifen—pancreatic cancer	0.00264	0.00437	CcSEcCtD
Betahistine—Convulsion—Fluorouracil—pancreatic cancer	0.00264	0.00437	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.00262	0.00434	CcSEcCtD
Betahistine—Confusional state—Irinotecan—pancreatic cancer	0.00262	0.00434	CcSEcCtD
Betahistine—Asthenia—Erlotinib—pancreatic cancer	0.00261	0.00433	CcSEcCtD
Betahistine—Discomfort—Gemcitabine—pancreatic cancer	0.0026	0.00432	CcSEcCtD
Betahistine—Pruritus—Tamoxifen—pancreatic cancer	0.0026	0.00431	CcSEcCtD
Betahistine—Anaphylactic shock—Irinotecan—pancreatic cancer	0.00259	0.0043	CcSEcCtD
Betahistine—Pruritus—Erlotinib—pancreatic cancer	0.00257	0.00427	CcSEcCtD
Betahistine—Discomfort—Fluorouracil—pancreatic cancer	0.00256	0.00425	CcSEcCtD
Betahistine—Nervous system disorder—Irinotecan—pancreatic cancer	0.00254	0.00422	CcSEcCtD
Betahistine—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.00253	0.00419	CcSEcCtD
Betahistine—Diarrhoea—Tamoxifen—pancreatic cancer	0.00252	0.00417	CcSEcCtD
Betahistine—Confusional state—Fluorouracil—pancreatic cancer	0.0025	0.00415	CcSEcCtD
Betahistine—Diarrhoea—Erlotinib—pancreatic cancer	0.00249	0.00413	CcSEcCtD
Betahistine—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.00248	0.00412	CcSEcCtD
Betahistine—Nervous system disorder—Gemcitabine—pancreatic cancer	0.00248	0.00411	CcSEcCtD
Betahistine—Skin disorder—Gemcitabine—pancreatic cancer	0.00245	0.00407	CcSEcCtD
Betahistine—Nervous system disorder—Fluorouracil—pancreatic cancer	0.00244	0.00404	CcSEcCtD
Betahistine—Dizziness—Tamoxifen—pancreatic cancer	0.00243	0.00403	CcSEcCtD
Betahistine—Tachycardia—Fluorouracil—pancreatic cancer	0.00242	0.00402	CcSEcCtD
Betahistine—Dizziness—Erlotinib—pancreatic cancer	0.00241	0.00399	CcSEcCtD
Betahistine—Erythema multiforme—Docetaxel—pancreatic cancer	0.00239	0.00396	CcSEcCtD
Betahistine—Vomiting—Tamoxifen—pancreatic cancer	0.00234	0.00388	CcSEcCtD
Betahistine—Hypersensitivity—Sunitinib—pancreatic cancer	0.00232	0.00385	CcSEcCtD
Betahistine—Rash—Tamoxifen—pancreatic cancer	0.00232	0.00384	CcSEcCtD
Betahistine—Dermatitis—Tamoxifen—pancreatic cancer	0.00232	0.00384	CcSEcCtD
Betahistine—Vomiting—Erlotinib—pancreatic cancer	0.00231	0.00384	CcSEcCtD
Betahistine—Dyspnoea—Irinotecan—pancreatic cancer	0.00231	0.00383	CcSEcCtD
Betahistine—Somnolence—Irinotecan—pancreatic cancer	0.00231	0.00382	CcSEcCtD
Betahistine—Headache—Tamoxifen—pancreatic cancer	0.0023	0.00382	CcSEcCtD
Betahistine—Rash—Erlotinib—pancreatic cancer	0.00229	0.0038	CcSEcCtD
Betahistine—Dermatitis—Erlotinib—pancreatic cancer	0.00229	0.0038	CcSEcCtD
Betahistine—Dyspepsia—Irinotecan—pancreatic cancer	0.00228	0.00379	CcSEcCtD
Betahistine—Immune system disorder—Docetaxel—pancreatic cancer	0.00228	0.00378	CcSEcCtD
Betahistine—Headache—Erlotinib—pancreatic cancer	0.00228	0.00378	CcSEcCtD
Betahistine—Asthenia—Sunitinib—pancreatic cancer	0.00226	0.00375	CcSEcCtD
Betahistine—Dyspnoea—Gemcitabine—pancreatic cancer	0.00225	0.00374	CcSEcCtD
Betahistine—Orthostatic hypotension—Epirubicin—pancreatic cancer	0.00225	0.00373	CcSEcCtD
Betahistine—Abdominal pain upper—Epirubicin—pancreatic cancer	0.00225	0.00373	CcSEcCtD
Betahistine—Somnolence—Gemcitabine—pancreatic cancer	0.00225	0.00373	CcSEcCtD
Betahistine—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.00224	0.00371	CcSEcCtD
Betahistine—Fatigue—Irinotecan—pancreatic cancer	0.00224	0.00371	CcSEcCtD
Betahistine—Pruritus—Sunitinib—pancreatic cancer	0.00223	0.00369	CcSEcCtD
Betahistine—Dyspnoea—Fluorouracil—pancreatic cancer	0.00221	0.00367	CcSEcCtD
Betahistine—Somnolence—Fluorouracil—pancreatic cancer	0.00221	0.00366	CcSEcCtD
Betahistine—Dyspepsia—Fluorouracil—pancreatic cancer	0.00219	0.00363	CcSEcCtD
Betahistine—Nausea—Tamoxifen—pancreatic cancer	0.00218	0.00362	CcSEcCtD
Betahistine—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.00218	0.00362	CcSEcCtD
Betahistine—Fatigue—Gemcitabine—pancreatic cancer	0.00218	0.00361	CcSEcCtD
Betahistine—Nausea—Erlotinib—pancreatic cancer	0.00216	0.00358	CcSEcCtD
Betahistine—Diarrhoea—Sunitinib—pancreatic cancer	0.00215	0.00357	CcSEcCtD
Betahistine—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.00214	0.00356	CcSEcCtD
Betahistine—Abdominal distension—Epirubicin—pancreatic cancer	0.00214	0.00355	CcSEcCtD
Betahistine—Feeling abnormal—Irinotecan—pancreatic cancer	0.00214	0.00354	CcSEcCtD
Betahistine—Asthma—Epirubicin—pancreatic cancer	0.00213	0.00353	CcSEcCtD
Betahistine—Dizziness—Sunitinib—pancreatic cancer	0.00208	0.00345	CcSEcCtD
Betahistine—Feeling abnormal—Gemcitabine—pancreatic cancer	0.00208	0.00345	CcSEcCtD
Betahistine—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.00208	0.00345	CcSEcCtD
Betahistine—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.00208	0.00345	CcSEcCtD
Betahistine—Feeling abnormal—Fluorouracil—pancreatic cancer	0.00205	0.00339	CcSEcCtD
Betahistine—Vomiting—Sunitinib—pancreatic cancer	0.002	0.00332	CcSEcCtD
Betahistine—Rash—Sunitinib—pancreatic cancer	0.00199	0.00329	CcSEcCtD
Betahistine—Dermatitis—Sunitinib—pancreatic cancer	0.00198	0.00329	CcSEcCtD
Betahistine—Abdominal distension—Doxorubicin—pancreatic cancer	0.00198	0.00329	CcSEcCtD
Betahistine—Urticaria—Fluorouracil—pancreatic cancer	0.00197	0.00327	CcSEcCtD
Betahistine—Headache—Sunitinib—pancreatic cancer	0.00197	0.00327	CcSEcCtD
Betahistine—Asthma—Doxorubicin—pancreatic cancer	0.00197	0.00326	CcSEcCtD
Betahistine—Hypersensitivity—Irinotecan—pancreatic cancer	0.00191	0.00317	CcSEcCtD
Betahistine—Convulsion—Docetaxel—pancreatic cancer	0.0019	0.00316	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.00188	0.00312	CcSEcCtD
Betahistine—Nausea—Sunitinib—pancreatic cancer	0.00187	0.0031	CcSEcCtD
Betahistine—Asthenia—Irinotecan—pancreatic cancer	0.00186	0.00309	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.00186	0.00308	CcSEcCtD
Betahistine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00183	0.00304	CcSEcCtD
Betahistine—Asthenia—Gemcitabine—pancreatic cancer	0.00181	0.00301	CcSEcCtD
Betahistine—Confusional state—Docetaxel—pancreatic cancer	0.00181	0.003	CcSEcCtD
Betahistine—Anaphylactic shock—Docetaxel—pancreatic cancer	0.00179	0.00297	CcSEcCtD
Betahistine—Pruritus—Gemcitabine—pancreatic cancer	0.00179	0.00296	CcSEcCtD
Betahistine—Diarrhoea—Irinotecan—pancreatic cancer	0.00177	0.00294	CcSEcCtD
Betahistine—Nervous system disorder—Docetaxel—pancreatic cancer	0.00176	0.00292	CcSEcCtD
Betahistine—Pruritus—Fluorouracil—pancreatic cancer	0.00176	0.00291	CcSEcCtD
Betahistine—Tachycardia—Docetaxel—pancreatic cancer	0.00175	0.0029	CcSEcCtD
Betahistine—Skin disorder—Docetaxel—pancreatic cancer	0.00174	0.00289	CcSEcCtD
Betahistine—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.00174	0.00288	CcSEcCtD
Betahistine—Diarrhoea—Gemcitabine—pancreatic cancer	0.00173	0.00287	CcSEcCtD
Betahistine—Dizziness—Irinotecan—pancreatic cancer	0.00172	0.00284	CcSEcCtD
Betahistine—Diarrhoea—Fluorouracil—pancreatic cancer	0.0017	0.00282	CcSEcCtD
Betahistine—Vomiting—Irinotecan—pancreatic cancer	0.00165	0.00273	CcSEcCtD
Betahistine—Dizziness—Fluorouracil—pancreatic cancer	0.00164	0.00272	CcSEcCtD
Betahistine—Rash—Irinotecan—pancreatic cancer	0.00164	0.00271	CcSEcCtD
Betahistine—Dermatitis—Irinotecan—pancreatic cancer	0.00163	0.00271	CcSEcCtD
Betahistine—Headache—Irinotecan—pancreatic cancer	0.00162	0.00269	CcSEcCtD
Betahistine—Erythema multiforme—Epirubicin—pancreatic cancer	0.00161	0.00267	CcSEcCtD
Betahistine—Vomiting—Gemcitabine—pancreatic cancer	0.00161	0.00266	CcSEcCtD
Betahistine—Dyspnoea—Docetaxel—pancreatic cancer	0.0016	0.00265	CcSEcCtD
Betahistine—Somnolence—Docetaxel—pancreatic cancer	0.00159	0.00264	CcSEcCtD
Betahistine—Rash—Gemcitabine—pancreatic cancer	0.00159	0.00264	CcSEcCtD
Betahistine—Dermatitis—Gemcitabine—pancreatic cancer	0.00159	0.00264	CcSEcCtD
Betahistine—Headache—Gemcitabine—pancreatic cancer	0.00158	0.00262	CcSEcCtD
Betahistine—Vomiting—Fluorouracil—pancreatic cancer	0.00158	0.00262	CcSEcCtD
Betahistine—Dyspepsia—Docetaxel—pancreatic cancer	0.00158	0.00262	CcSEcCtD
Betahistine—Rash—Fluorouracil—pancreatic cancer	0.00157	0.0026	CcSEcCtD
Betahistine—Dermatitis—Fluorouracil—pancreatic cancer	0.00156	0.0026	CcSEcCtD
Betahistine—Headache—Fluorouracil—pancreatic cancer	0.00156	0.00258	CcSEcCtD
Betahistine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.00155	0.00257	CcSEcCtD
Betahistine—Fatigue—Docetaxel—pancreatic cancer	0.00155	0.00256	CcSEcCtD
Betahistine—Nausea—Irinotecan—pancreatic cancer	0.00154	0.00256	CcSEcCtD
Betahistine—Immune system disorder—Epirubicin—pancreatic cancer	0.00154	0.00255	CcSEcCtD
Betahistine—Nausea—Gemcitabine—pancreatic cancer	0.0015	0.00249	CcSEcCtD
Betahistine—Erythema multiforme—Doxorubicin—pancreatic cancer	0.00149	0.00247	CcSEcCtD
Betahistine—Feeling abnormal—Docetaxel—pancreatic cancer	0.00148	0.00245	CcSEcCtD
Betahistine—Nausea—Fluorouracil—pancreatic cancer	0.00148	0.00245	CcSEcCtD
Betahistine—Flatulence—Epirubicin—pancreatic cancer	0.00146	0.00242	CcSEcCtD
Betahistine—Immune system disorder—Doxorubicin—pancreatic cancer	0.00142	0.00236	CcSEcCtD
Betahistine—Ill-defined disorder—Epirubicin—pancreatic cancer	0.00137	0.00228	CcSEcCtD
Betahistine—Flatulence—Doxorubicin—pancreatic cancer	0.00135	0.00224	CcSEcCtD
Betahistine—Malaise—Epirubicin—pancreatic cancer	0.00134	0.00222	CcSEcCtD
Betahistine—Hypersensitivity—Docetaxel—pancreatic cancer	0.00132	0.00219	CcSEcCtD
Betahistine—Asthenia—Docetaxel—pancreatic cancer	0.00129	0.00213	CcSEcCtD
Betahistine—Convulsion—Epirubicin—pancreatic cancer	0.00128	0.00213	CcSEcCtD
Betahistine—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.00127	0.00211	CcSEcCtD
Betahistine—Pruritus—Docetaxel—pancreatic cancer	0.00127	0.0021	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.00125	0.00208	CcSEcCtD
Betahistine—Discomfort—Epirubicin—pancreatic cancer	0.00125	0.00207	CcSEcCtD
Betahistine—Malaise—Doxorubicin—pancreatic cancer	0.00124	0.00205	CcSEcCtD
Betahistine—Diarrhoea—Docetaxel—pancreatic cancer	0.00123	0.00203	CcSEcCtD
Betahistine—Confusional state—Epirubicin—pancreatic cancer	0.00122	0.00202	CcSEcCtD
Betahistine—Anaphylactic shock—Epirubicin—pancreatic cancer	0.00121	0.00201	CcSEcCtD
Betahistine—Convulsion—Doxorubicin—pancreatic cancer	0.00119	0.00197	CcSEcCtD
Betahistine—Nervous system disorder—Epirubicin—pancreatic cancer	0.00119	0.00197	CcSEcCtD
Betahistine—Dizziness—Docetaxel—pancreatic cancer	0.00119	0.00197	CcSEcCtD
Betahistine—Tachycardia—Epirubicin—pancreatic cancer	0.00118	0.00196	CcSEcCtD
Betahistine—Skin disorder—Epirubicin—pancreatic cancer	0.00117	0.00195	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.00116	0.00192	CcSEcCtD
Betahistine—HRH1—G alpha (q) signalling events—GCG—pancreatic cancer	0.00115	0.00291	CbGpPWpGaD
Betahistine—Discomfort—Doxorubicin—pancreatic cancer	0.00115	0.00191	CcSEcCtD
Betahistine—HRH1—GPCR ligand binding—SSTR2—pancreatic cancer	0.00115	0.00289	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—DTX1—pancreatic cancer	0.00114	0.00287	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—SSTR3—pancreatic cancer	0.00114	0.00287	CbGpPWpGaD
Betahistine—Vomiting—Docetaxel—pancreatic cancer	0.00114	0.00189	CcSEcCtD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCK—pancreatic cancer	0.00113	0.00285	CbGpPWpGaD
Betahistine—Rash—Docetaxel—pancreatic cancer	0.00113	0.00187	CcSEcCtD
Betahistine—Dermatitis—Docetaxel—pancreatic cancer	0.00113	0.00187	CcSEcCtD
Betahistine—Confusional state—Doxorubicin—pancreatic cancer	0.00113	0.00187	CcSEcCtD
Betahistine—Headache—Docetaxel—pancreatic cancer	0.00112	0.00186	CcSEcCtD
Betahistine—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.00112	0.00186	CcSEcCtD
Betahistine—HRH3—GPCR downstream signaling—SST—pancreatic cancer	0.00112	0.00281	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—PTHLH—pancreatic cancer	0.00111	0.00279	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—PTCH1—pancreatic cancer	0.00111	0.00279	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—CCKBR—pancreatic cancer	0.00111	0.00279	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—CNR2—pancreatic cancer	0.0011	0.00278	CbGpPWpGaD
Betahistine—HRH1—G alpha (q) signalling events—AGTR1—pancreatic cancer	0.0011	0.00277	CbGpPWpGaD
Betahistine—Nervous system disorder—Doxorubicin—pancreatic cancer	0.0011	0.00182	CcSEcCtD
Betahistine—HRH1—IL-4 Signaling Pathway—STAT3—pancreatic cancer	0.0011	0.00276	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—SSTR1—pancreatic cancer	0.00109	0.00275	CbGpPWpGaD
Betahistine—Tachycardia—Doxorubicin—pancreatic cancer	0.00109	0.00181	CcSEcCtD
Betahistine—Skin disorder—Doxorubicin—pancreatic cancer	0.00109	0.0018	CcSEcCtD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCKAR—pancreatic cancer	0.00108	0.00273	CbGpPWpGaD
Betahistine—Dyspnoea—Epirubicin—pancreatic cancer	0.00108	0.00179	CcSEcCtD
Betahistine—Somnolence—Epirubicin—pancreatic cancer	0.00108	0.00178	CcSEcCtD
Betahistine—HRH3—Signaling Pathways—PPY—pancreatic cancer	0.00107	0.0027	CbGpPWpGaD
Betahistine—Nausea—Docetaxel—pancreatic cancer	0.00106	0.00177	CcSEcCtD
Betahistine—Dyspepsia—Epirubicin—pancreatic cancer	0.00106	0.00177	CcSEcCtD
Betahistine—HRH3—Signaling Pathways—SSTR2—pancreatic cancer	0.00105	0.00265	CbGpPWpGaD
Betahistine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.00104	0.00173	CcSEcCtD
Betahistine—Fatigue—Epirubicin—pancreatic cancer	0.00104	0.00173	CcSEcCtD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GCG—pancreatic cancer	0.00103	0.0026	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—CNR1—pancreatic cancer	0.00103	0.0026	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CCKBR—pancreatic cancer	0.00102	0.00256	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—SST—pancreatic cancer	0.00101	0.00255	CbGpPWpGaD
Betahistine—HRH3—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.00101	0.00255	CbGpPWpGaD
Betahistine—Dyspnoea—Doxorubicin—pancreatic cancer	0.000998	0.00165	CcSEcCtD
Betahistine—Feeling abnormal—Epirubicin—pancreatic cancer	0.000997	0.00165	CcSEcCtD
Betahistine—HRH3—GPCR downstream signaling—GCG—pancreatic cancer	0.000995	0.00251	CbGpPWpGaD
Betahistine—Somnolence—Doxorubicin—pancreatic cancer	0.000995	0.00165	CcSEcCtD
Betahistine—Dyspepsia—Doxorubicin—pancreatic cancer	0.000985	0.00163	CcSEcCtD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—pancreatic cancer	0.000984	0.00248	CbGpPWpGaD
Betahistine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000966	0.0016	CcSEcCtD
Betahistine—Fatigue—Doxorubicin—pancreatic cancer	0.000965	0.0016	CcSEcCtD
Betahistine—Urticaria—Epirubicin—pancreatic cancer	0.000961	0.00159	CcSEcCtD
Betahistine—HRH3—Signaling Pathways—GLI1—pancreatic cancer	0.000956	0.00241	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—DTX4—pancreatic cancer	0.000956	0.00241	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—AGTR1—pancreatic cancer	0.00095	0.00239	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—CNR1—pancreatic cancer	0.000936	0.00236	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—NRP1—pancreatic cancer	0.00093	0.00234	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PPP2R5B—pancreatic cancer	0.00093	0.00234	CbGpPWpGaD
Betahistine—HRH1—GPCRs, Class A Rhodopsin-like—CNR1—pancreatic cancer	0.000924	0.00233	CbGpPWpGaD
Betahistine—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000922	0.00153	CcSEcCtD
Betahistine—HRH3—Signaling by GPCR—GCG—pancreatic cancer	0.000904	0.00228	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—SCT—pancreatic cancer	0.000903	0.00227	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—HEY2—pancreatic cancer	0.000895	0.00225	CbGpPWpGaD
Betahistine—Hypersensitivity—Epirubicin—pancreatic cancer	0.000891	0.00148	CcSEcCtD
Betahistine—Urticaria—Doxorubicin—pancreatic cancer	0.000889	0.00147	CcSEcCtD
Betahistine—HRH3—Signaling Pathways—GAST—pancreatic cancer	0.000874	0.0022	CbGpPWpGaD
Betahistine—Asthenia—Epirubicin—pancreatic cancer	0.000868	0.00144	CcSEcCtD
Betahistine—HRH1—IL-4 Signaling Pathway—PIK3CA—pancreatic cancer	0.000864	0.00218	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—AGTR1—pancreatic cancer	0.000862	0.00217	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—CCK—pancreatic cancer	0.000861	0.00217	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—SST—pancreatic cancer	0.000857	0.00216	CbGpPWpGaD
Betahistine—Pruritus—Epirubicin—pancreatic cancer	0.000856	0.00142	CcSEcCtD
Betahistine—HRH1—GPCRs, Class A Rhodopsin-like—AGTR1—pancreatic cancer	0.000851	0.00214	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—CNR2—pancreatic cancer	0.00084	0.00211	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—GLP1R—pancreatic cancer	0.00084	0.00211	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—SCT—pancreatic cancer	0.000829	0.00209	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—HEY1—pancreatic cancer	0.000829	0.00209	CbGpPWpGaD
Betahistine—Diarrhoea—Epirubicin—pancreatic cancer	0.000827	0.00137	CcSEcCtD
Betahistine—HRH1—GPCR ligand binding—CCKAR—pancreatic cancer	0.000826	0.00208	CbGpPWpGaD
Betahistine—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000824	0.00137	CcSEcCtD
Betahistine—Asthenia—Doxorubicin—pancreatic cancer	0.000803	0.00133	CcSEcCtD
Betahistine—Dizziness—Epirubicin—pancreatic cancer	0.0008	0.00133	CcSEcCtD
Betahistine—Pruritus—Doxorubicin—pancreatic cancer	0.000792	0.00131	CcSEcCtD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—CNR1—pancreatic cancer	0.000791	0.00199	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CCK—pancreatic cancer	0.000791	0.00199	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CNR2—pancreatic cancer	0.00077	0.00194	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—GLP1R—pancreatic cancer	0.00077	0.00194	CbGpPWpGaD
Betahistine—HRH3—GPCR ligand binding—CXCL8—pancreatic cancer	0.00077	0.00194	CbGpPWpGaD
Betahistine—Vomiting—Epirubicin—pancreatic cancer	0.000769	0.00128	CcSEcCtD
Betahistine—Diarrhoea—Doxorubicin—pancreatic cancer	0.000766	0.00127	CcSEcCtD
Betahistine—Rash—Epirubicin—pancreatic cancer	0.000762	0.00126	CcSEcCtD
Betahistine—Dermatitis—Epirubicin—pancreatic cancer	0.000762	0.00126	CcSEcCtD
Betahistine—HRH3—Signaling Pathways—CCKAR—pancreatic cancer	0.000758	0.00191	CbGpPWpGaD
Betahistine—Headache—Epirubicin—pancreatic cancer	0.000758	0.00126	CcSEcCtD
Betahistine—HRH1—GPCR ligand binding—SHH—pancreatic cancer	0.000753	0.0019	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—PRLHR—pancreatic cancer	0.00075	0.00189	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—IAPP—pancreatic cancer	0.000744	0.00187	CbGpPWpGaD
Betahistine—Dizziness—Doxorubicin—pancreatic cancer	0.00074	0.00123	CcSEcCtD
Betahistine—HRH3—Signaling Pathways—JAG2—pancreatic cancer	0.000735	0.00185	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—AGTR1—pancreatic cancer	0.000729	0.00184	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—MEN1—pancreatic cancer	0.000724	0.00182	CbGpPWpGaD
Betahistine—Nausea—Epirubicin—pancreatic cancer	0.000718	0.00119	CcSEcCtD
Betahistine—HRH1—GPCR ligand binding—PTHLH—pancreatic cancer	0.000714	0.0018	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—PTCH1—pancreatic cancer	0.000714	0.0018	CbGpPWpGaD
Betahistine—Vomiting—Doxorubicin—pancreatic cancer	0.000711	0.00118	CcSEcCtD
Betahistine—HRH1—IL-4 Signaling Pathway—AKT1—pancreatic cancer	0.000706	0.00178	CbGpPWpGaD
Betahistine—Rash—Doxorubicin—pancreatic cancer	0.000706	0.00117	CcSEcCtD
Betahistine—Dermatitis—Doxorubicin—pancreatic cancer	0.000705	0.00117	CcSEcCtD
Betahistine—HRH1—GPCR downstream signaling—SSTR3—pancreatic cancer	0.000702	0.00177	CbGpPWpGaD
Betahistine—Headache—Doxorubicin—pancreatic cancer	0.000701	0.00116	CcSEcCtD
Betahistine—HRH3—Signaling Pathways—SHH—pancreatic cancer	0.000691	0.00174	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—GDI1—pancreatic cancer	0.000688	0.00173	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—GDI2—pancreatic cancer	0.000688	0.00173	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—NOTCH4—pancreatic cancer	0.000687	0.00173	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—IAPP—pancreatic cancer	0.000682	0.00172	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—SSTR1—pancreatic cancer	0.000673	0.0017	CbGpPWpGaD
Betahistine—Nausea—Doxorubicin—pancreatic cancer	0.000665	0.0011	CcSEcCtD
Betahistine—HRH1—GPCR downstream signaling—PPY—pancreatic cancer	0.00066	0.00166	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PTHLH—pancreatic cancer	0.000655	0.00165	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PTCH1—pancreatic cancer	0.000655	0.00165	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—SST—pancreatic cancer	0.000653	0.00164	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—SSTR2—pancreatic cancer	0.000648	0.00163	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—SSTR3—pancreatic cancer	0.000638	0.00161	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—CCKBR—pancreatic cancer	0.000626	0.00158	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—SSTR1—pancreatic cancer	0.000611	0.00154	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—CNR1—pancreatic cancer	0.000603	0.00152	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—PPY—pancreatic cancer	0.0006	0.00151	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—SST—pancreatic cancer	0.000599	0.00151	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000591	0.00149	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—SSTR2—pancreatic cancer	0.000589	0.00148	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—JAG1—pancreatic cancer	0.000586	0.00148	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—NOTCH3—pancreatic cancer	0.000584	0.00147	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—GCG—pancreatic cancer	0.000582	0.00147	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CCKBR—pancreatic cancer	0.000568	0.00143	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—AGTR1—pancreatic cancer	0.000555	0.0014	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CNR1—pancreatic cancer	0.000553	0.00139	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—GAST—pancreatic cancer	0.000538	0.00136	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000537	0.00135	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—GCG—pancreatic cancer	0.000534	0.00134	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000519	0.00131	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—SCT—pancreatic cancer	0.00051	0.00129	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—AGTR1—pancreatic cancer	0.000509	0.00128	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—STK11—pancreatic cancer	0.000502	0.00126	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—GAST—pancreatic cancer	0.000489	0.00123	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—CCK—pancreatic cancer	0.000487	0.00123	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—CNR2—pancreatic cancer	0.000474	0.00119	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—GLP1R—pancreatic cancer	0.000474	0.00119	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000472	0.00119	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—CCKAR—pancreatic cancer	0.000467	0.00118	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—SCT—pancreatic cancer	0.000463	0.00117	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000453	0.00114	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PRLHR—pancreatic cancer	0.000443	0.00112	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CCK—pancreatic cancer	0.000442	0.00111	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—SMAD4—pancreatic cancer	0.00044	0.00111	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000435	0.0011	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—GLP1R—pancreatic cancer	0.000431	0.00109	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CNR2—pancreatic cancer	0.000431	0.00109	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—HES1—pancreatic cancer	0.000429	0.00108	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CCKAR—pancreatic cancer	0.000424	0.00107	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—IAPP—pancreatic cancer	0.00042	0.00106	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—ZNRF3—pancreatic cancer	0.000417	0.00105	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—ACVR1B—pancreatic cancer	0.000417	0.00105	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000411	0.00104	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—PTHLH—pancreatic cancer	0.000403	0.00102	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—CXCL8—pancreatic cancer	0.000395	0.000995	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—SHH—pancreatic cancer	0.000386	0.000973	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—IAPP—pancreatic cancer	0.000382	0.000961	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—SSTR3—pancreatic cancer	0.000377	0.000949	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—DTX1—pancreatic cancer	0.000377	0.000949	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—TERT—pancreatic cancer	0.000376	0.000948	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—SST—pancreatic cancer	0.000369	0.000929	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—PTHLH—pancreatic cancer	0.000366	0.000923	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—PTCH1—pancreatic cancer	0.000366	0.000923	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—pancreatic cancer	0.000362	0.000911	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—SSTR1—pancreatic cancer	0.000361	0.00091	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—HIF1A—pancreatic cancer	0.00036	0.000906	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—TSC2—pancreatic cancer	0.000359	0.000904	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PPY—pancreatic cancer	0.000354	0.000892	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—APOE—pancreatic cancer	0.000351	0.000885	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—SSTR2—pancreatic cancer	0.000348	0.000876	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—KDR—pancreatic cancer	0.000344	0.000867	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—CNR1—pancreatic cancer	0.00034	0.000858	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CCKBR—pancreatic cancer	0.000336	0.000846	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—SST—pancreatic cancer	0.000335	0.000844	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.000334	0.000841	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pancreatic cancer	0.00033	0.00083	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—GCG—pancreatic cancer	0.000329	0.000828	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—NFKBIA—pancreatic cancer	0.000327	0.000824	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—NOTCH1—pancreatic cancer	0.000324	0.000816	CbGpPWpGaD
Betahistine—HRH1—G alpha (q) signalling events—PIK3CA—pancreatic cancer	0.00032	0.000806	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PIK3CG—pancreatic cancer	0.000317	0.000798	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—NRAS—pancreatic cancer	0.000317	0.000798	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—GLI1—pancreatic cancer	0.000316	0.000795	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—DTX4—pancreatic cancer	0.000316	0.000795	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000314	0.00079	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—EGF—pancreatic cancer	0.000313	0.000789	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatic cancer	0.000311	0.000784	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CNR1—pancreatic cancer	0.000309	0.000779	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000307	0.000774	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—NRP1—pancreatic cancer	0.000307	0.000774	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—GCG—pancreatic cancer	0.000299	0.000752	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—HEY2—pancreatic cancer	0.000296	0.000745	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—EGFR—pancreatic cancer	0.000289	0.000727	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—GAST—pancreatic cancer	0.000289	0.000727	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—pancreatic cancer	0.000286	0.000721	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—AGTR1—pancreatic cancer	0.000285	0.000717	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PIK3CD—pancreatic cancer	0.000279	0.000702	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000276	0.000695	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—SCT—pancreatic cancer	0.000274	0.000689	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—HEY1—pancreatic cancer	0.000274	0.000689	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—KRAS—pancreatic cancer	0.000273	0.000687	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	0.000265	0.000667	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CCK—pancreatic cancer	0.000261	0.000658	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CNR2—pancreatic cancer	0.000255	0.000641	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—GLP1R—pancreatic cancer	0.000255	0.000641	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—CXCL8—pancreatic cancer	0.000254	0.000641	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—PIK3CA—pancreatic cancer	0.000251	0.000631	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CCKAR—pancreatic cancer	0.00025	0.000631	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PIK3CB—pancreatic cancer	0.000243	0.000612	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—JAG2—pancreatic cancer	0.000243	0.000611	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—MEN1—pancreatic cancer	0.000239	0.000603	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CXCL8—pancreatic cancer	0.000233	0.000588	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—HRAS—pancreatic cancer	0.000232	0.000584	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—SHH—pancreatic cancer	0.000228	0.000575	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—NOTCH4—pancreatic cancer	0.000227	0.000571	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—AKT1—pancreatic cancer	0.000225	0.000568	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—IAPP—pancreatic cancer	0.000225	0.000568	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CASP3—pancreatic cancer	0.000223	0.000563	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CCND1—pancreatic cancer	0.000217	0.000548	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PTHLH—pancreatic cancer	0.000216	0.000545	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PTCH1—pancreatic cancer	0.000216	0.000545	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—CTNNB1—pancreatic cancer	0.000215	0.000542	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—MMP9—pancreatic cancer	0.000211	0.000532	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PTEN—pancreatic cancer	0.00021	0.000529	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—AKT1—pancreatic cancer	0.000205	0.000516	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—SST—pancreatic cancer	0.000198	0.000498	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000195	0.000492	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—SRC—pancreatic cancer	0.000195	0.00049	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—JAG1—pancreatic cancer	0.000194	0.000488	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—NOTCH3—pancreatic cancer	0.000193	0.000486	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—VEGFA—pancreatic cancer	0.00019	0.000477	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—STAT3—pancreatic cancer	0.000188	0.000473	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—NRAS—pancreatic cancer	0.000187	0.000472	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CNR1—pancreatic cancer	0.000183	0.00046	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000177	0.000446	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—GCG—pancreatic cancer	0.000176	0.000444	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—MYC—pancreatic cancer	0.000174	0.000439	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—TGFB1—pancreatic cancer	0.000174	0.000438	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000172	0.000432	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—EGFR—pancreatic cancer	0.000171	0.00043	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—AGTR1—pancreatic cancer	0.000168	0.000424	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—STK11—pancreatic cancer	0.000166	0.000418	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—KRAS—pancreatic cancer	0.000161	0.000406	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000156	0.000392	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.00015	0.000377	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PIK3CA—pancreatic cancer	0.000148	0.000373	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—SMAD4—pancreatic cancer	0.000145	0.000366	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000144	0.000362	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—TP53—pancreatic cancer	0.000143	0.000361	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—HES1—pancreatic cancer	0.000142	0.000357	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—HRAS—pancreatic cancer	0.000137	0.000345	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000136	0.000342	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—CXCL8—pancreatic cancer	0.000131	0.000329	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—TERT—pancreatic cancer	0.000124	0.000313	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—AKT1—pancreatic cancer	0.000121	0.000305	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—HIF1A—pancreatic cancer	0.000119	0.000299	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—TSC2—pancreatic cancer	0.000119	0.000299	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—APOE—pancreatic cancer	0.000116	0.000292	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—KDR—pancreatic cancer	0.000114	0.000286	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—NFKBIA—pancreatic cancer	0.000108	0.000272	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—NOTCH1—pancreatic cancer	0.000107	0.00027	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PIK3CG—pancreatic cancer	0.000105	0.000264	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—NRAS—pancreatic cancer	0.000105	0.000264	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—EGF—pancreatic cancer	0.000104	0.000261	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—EGFR—pancreatic cancer	9.54e-05	0.00024	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PIK3CD—pancreatic cancer	9.21e-05	0.000232	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—PIK3CA—pancreatic cancer	9.12e-05	0.00023	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—KRAS—pancreatic cancer	9.01e-05	0.000227	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—PIK3CA—pancreatic cancer	8.28e-05	0.000209	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PIK3CB—pancreatic cancer	8.02e-05	0.000202	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CXCL8—pancreatic cancer	7.71e-05	0.000194	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—HRAS—pancreatic cancer	7.66e-05	0.000193	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—AKT1—pancreatic cancer	7.45e-05	0.000188	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CASP3—pancreatic cancer	7.38e-05	0.000186	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CCND1—pancreatic cancer	7.18e-05	0.000181	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—CTNNB1—pancreatic cancer	7.11e-05	0.000179	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—MMP9—pancreatic cancer	6.97e-05	0.000176	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PTEN—pancreatic cancer	6.93e-05	0.000175	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—AKT1—pancreatic cancer	6.76e-05	0.00017	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—SRC—pancreatic cancer	6.43e-05	0.000162	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—VEGFA—pancreatic cancer	6.26e-05	0.000158	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—STAT3—pancreatic cancer	6.2e-05	0.000156	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—NRAS—pancreatic cancer	6.19e-05	0.000156	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—MYC—pancreatic cancer	5.76e-05	0.000145	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—TGFB1—pancreatic cancer	5.75e-05	0.000145	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—EGFR—pancreatic cancer	5.64e-05	0.000142	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—KRAS—pancreatic cancer	5.32e-05	0.000134	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PIK3CA—pancreatic cancer	4.89e-05	0.000123	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—TP53—pancreatic cancer	4.73e-05	0.000119	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—HRAS—pancreatic cancer	4.53e-05	0.000114	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—AKT1—pancreatic cancer	4e-05	0.000101	CbGpPWpGaD
